Microsoft is taking an impressive step in modernizing its biggest codebases and will eliminate all C/C++ code by the end of the decade, replacing it with Rust. “My goal is to eliminate every line of C ...

DTI is known for generous number of codes that devs share with the community. If you want to see some of them, go to our guide that lists them all. However, new ones are often added. Right now, with ...

“We do one book after state testing, and we did ‘The Great Gatsby.’ … A lot of kids had not read a novel in class before.” — Laura Henry, 10th-grade English teacher near Houston “My son in 9th grade ...

The State Corporation Commission on Tuesday handed Dominion Energy two major approvals, after the board OK’d the controversial Chesterfield Energy Reliability Center as well as the utility’s new rates ...

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Google has entered the fast-emerging category of AI-first coding environments with Google Antigravity, an agentic development platform that aims to reimagine the IDE in the era of autonomous coding ...

Epcoritamab-bysp, combined with rituximab and lenalidomide, is FDA-approved for relapsed follicular lymphoma, marking a significant advancement in second-line treatment. The EPCORE FL-1 trial showed a ...

If you are tired of typing passwords or dealing with login issues, Outlook QR code sign in is one of the fastest and most secure ways to access your account. It connects your Microsoft account to your ...

Cybersecurity researchers have disclosed a new set of three extensions associated with the GlassWorm campaign, indicating continued attempts on part of threat actors to target the Visual Studio Code ...

Cybersecurity researchers have flagged a malicious Visual Studio Code (VS Code) extension with basic ransomware capabilities that appears to be created with the help of artificial intelligence – in ...

Findings showed oral semaglutide statistically significantly reduced the risk of MACE by 14% compared with placebo at 4 years. The Food and Drug Administration (FDA) has approved Rybelsus ® ...